These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 27572081)

  • 1. The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.
    Wu W; Liu S
    Curr Top Med Chem; 2017; 17(3):361-370. PubMed ID: 27572081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of treatment strategies to combat Ebola and Marburg viruses.
    Paragas J; Geisbert TW
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease.
    Schafer A; Cheng H; Lee C; Du R; Han J; Perez J; Peet N; Manicassamy B; Rong L
    Curr Med Chem; 2018; 25(38):5177-5190. PubMed ID: 29032747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.
    Chiramel AI; Banadyga L; Dougherty JD; Falzarano D; Martellaro C; Brees D; Taylor RT; Ebihara H; Best SM
    J Infect Dis; 2016 Oct; 214(suppl 3):S355-S359. PubMed ID: 27511894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Will There Be a Cure for Ebola?
    Cardile AP; Warren TK; Martins KA; Reisler RB; Bavari S
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():329-348. PubMed ID: 27959624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of therapeutics for treatment of Ebola virus infection.
    Li H; Ying T; Yu F; Lu L; Jiang S
    Microbes Infect; 2015 Feb; 17(2):109-17. PubMed ID: 25498866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule inhibitors of ebola virus infection.
    Picazo E; Giordanetto F
    Drug Discov Today; 2015 Feb; 20(2):277-86. PubMed ID: 25532798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral therapeutics for the treatment of Ebola virus infection.
    Cardile AP; Downey LG; Wiseman PD; Warren TK; Bavari S
    Curr Opin Pharmacol; 2016 Oct; 30():138-143. PubMed ID: 27639220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of Ebola Therapeutics During the 2014-2015 Outbreak.
    Mendoza EJ; Qiu X; Kobinger GP
    Trends Mol Med; 2016 Feb; 22(2):164-173. PubMed ID: 26774636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary Anti-Ebola Drug Discovery Approaches and Platforms.
    Schneider-Futschik EK; Hoyer D; Khromykh AA; Baell JB; Marsh GA; Baker MA; Li J; Velkov T
    ACS Infect Dis; 2019 Jan; 5(1):35-48. PubMed ID: 30516045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.
    Kroeker A; Griffin BD; Qiu X; Kobinger G
    Methods Mol Biol; 2017; 1628():273-282. PubMed ID: 28573628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress towards the treatment of Ebola haemorrhagic fever.
    Ströher U; Feldmann H
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1523-35. PubMed ID: 17107278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Therapeutic Approaches Against Ebola Virus Infection.
    Soni M; Tulsian K; Barot P; Vyas VK
    Recent Adv Antiinfect Drug Discov; 2024; 19(4):276-299. PubMed ID: 38279760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review on the antagonist Ebola: A prophylactic approach.
    Khan FN; Qazi S; Tanveer K; Raza K
    Biomed Pharmacother; 2017 Dec; 96():1513-1526. PubMed ID: 29208326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ebola virus disease.
    Kilgore PE; Grabenstein JD; Salim AM; Rybak M
    Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.
    Dhama K; Karthik K; Khandia R; Chakraborty S; Munjal A; Latheef SK; Kumar D; Ramakrishnan MA; Malik YS; Singh R; Malik SVS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():1803. PubMed ID: 30147687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Strategies against Ebola Virus Infection.
    Liu CH; Hu YT; Wong SH; Lin LT
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.